A phase 1/2 study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors Meeting Abstract

  

Authors:	Dela Cruz, F.; Fox, E.; Muscal, J.; Kirov, I.; Geller, J.; Dubois, S.; Kim, A.; Croop, J.; Laetsch, T.; Minard, C.; Liu, X.; Weigel, B.; Okpara, C.; Huang, J.; Dutta, L.; Aluri, J.; Glade Bender, J.
Abstract Title:	A phase 1/2 study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors
Meeting Title:	52nd Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title:	Pediatric Blood and Cancer
Volume:	67
Issue:	Suppl. 4
Meeting Dates:	2020 Oct 14-17
Meeting Location:	Virtual
ISSN:	1545-5009
Publisher:	Wiley Periodicals, Inc
Date Published:	2020-12-01
Start Page:	S20
End Page:	S21
Language:	English
ACCESSION:	WOS:000581769200036
PROVIDER:	wos
PUBMED:	33049088
DOI:	10.1002/pbc.28742
Notes:	Meeting Abstract: 0034 / #238 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/175582